Abstract
Lymphocytic myocarditis (LM) is a rare condition with a broad spectrum of clinical
presentations. Complete heart block (CHB) is an uncommon sequela. We present a case
of a young man with biopsy-proven LM who presented with cardiogenic shock and went
on to develop nonresolving CHB, requiring permanent pacemaker implantation.
Résumé
Une myocardite lymphocytaire est une affection rare se manifestant par un large éventail
de tableaux cliniques. Le bloc auriculo-ventriculaire complet (BAVC) en est une séquelle
peu fréquente. Nous présentons le cas d'un jeune homme atteint de myocardite lymphocytaire
confirmée par biopsie, ayant présenté initialement un choc cardiogène puis un BAVC
non résolutif ayant nécessité l'implantation d'un stimulateur cardiaque permanent.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Myocarditis.Circ Res. 2016; 118: 496-514
- Giant cell versus lymphocytic myocarditis: a comparison of their clinical features and long-term outcomes.Circulation. 1991; 83: 953-961
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases.Eur Heart J. 2013; 34: 2636-2648
- Recurrence of myocarditis presenting as pacing and sensing failure after implantation of a permanent pacemaker at first onset.Jpn Circ J. 2001; 65: 345-348
- Virus-negative active lymphocytic myocarditis progressing to a fibrotic stage.Case Rep Med. 2011; 740928
Article info
Publication history
Published online: June 17, 2021
Accepted:
June 4,
2021
Received:
April 14,
2021
Footnotes
See page 1658 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
